Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant-Associated Thrombotic Microangiopathy (TA-TMA)”

6 trials

Showing 6 of 6 results

Not applicableNot Yet RecruitingNCT07381205
What this trial is testing

Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)

Who this might be right for
Transplant Associated Microangiopathy TAMTransplant Complication
Manuel Ricardo Espinoza-Gutarra 85
Testing effectiveness (Phase 2)Looking for participantsNCT07707687
What this trial is testing

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University 24
Not applicableLooking for participantsNCT07347990
What this trial is testing

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyHematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University 30
Large-scale testing (Phase 3)Study completedNCT03252925
What this trial is testing

A Safety and Efficacy Study of NAC in Patients With TA-TMA

Who this might be right for
Thrombotic MicroangiopathiesHematologic Diseases
The First Affiliated Hospital of Soochow University 170
Not applicableLooking for participantsNCT06102694
What this trial is testing

Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 500
Testing effectiveness (Phase 2)Study completedNCT05148299
What this trial is testing

Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy
Swedish Orphan Biovitrum 12

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation